Stock Events

Stock Events

Search...

Regeneron Pharmaceuticals (REGN) Q4 2020 Earnings

5NovConfirmed

Q1 2020

Q2 2020

Q3 2020

Q4 2020

5.73

6.61

7.48

8.36

Details

Expected EPS

7.32

Actual EPS

8.36

Surprise EPS

1.04

Surprise Percent

+14.21%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 8.36 per share for Q4 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.